In agreement with this, we found that TRPML1 activity was inhibited in cells from Fabry disease patient, as indicated by a decrease in TRPML1-meidated lysosomal Ca2+ release in respond to ML-SA1 (Fig. 7D,E,H). This evidence concerns the gene MCOLN1 and Fabry disease.